Brief: Inspira™ Technologies Announces First In Human Of Hyla™ Blood Sensor In Clinical Study
22/03/2023 12:32
March 22 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA™ TECHNOLOGIES ANNOUNCES FIRST IN HUMAN OF HYLA™
BLOOD
SENSOR IN CLINICAL STUDY
* INSPIRA TECHNOLOGIES OXY BHN LTD - FIRST USE OF HYLA IN A
PATIENT UNDERGOING OPEN-HEART SURGERY AT SHEBA MEDICAL CENTER IN
ISRAEL
Source text for Eikon: ID:nPn7JkxYha
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM